Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
50 hedge funds and large institutions have $38.6M invested in Repare Therapeutics in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 11 closing their positions.
33% more capital invested
Capital invested by funds: $29.1M → $38.6M (+$9.49M)
0% more funds holding
Funds holding: 50 → 50 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
4.72% less ownership
Funds ownership: 69.42% → 64.7% (-4.7%)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
+$464K |
| 2 |
Millennium Management
New York
|
+$335K |
| 3 |
Renaissance Technologies
New York
|
+$292K |
| 4 |
MCP
Militia Capital Partners
Las Vegas,
Nevada
|
+$155K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$56.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.11M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$389K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$52.3K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$52.1K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$42.1K |
RPTX Hedge Fund Activity: Q2 2025 in Review
50 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q2 2025, worth a combined $38.6M — up 33% from $29.1M a quarter earlier.
Fund positioning in RPTX was balanced in Q2 2025: 11 funds opened new positions, 11 closed out, 4 added to existing stakes and 11 trimmed.
The largest buyer was Rangeley Capital, opening a new position worth an estimated $464K. The largest seller was ARK Investment Management, exiting entirely with an estimated $1.11M sold.
- 50 institutional investors held Repare Therapeutics (RPTX) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $38.6M of Repare Therapeutics stock for Q2 2025, up 33% quarter-over-quarter.
- 11 funds opened new Repare Therapeutics positions in Q2 2025 and 11 closed out, a net change of 0 holders.
- The largest Repare Therapeutics buyer in Q2 2025 was Rangeley Capital, an estimated $464K added.
- The largest Repare Therapeutics seller in Q2 2025 was ARK Investment Management, an estimated $1.11M sold.
Based on aggregated 13F filings for Q2 2025.